Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Retained Earnings (2016 - 2025)

Nephros (NEPH) has 16 years of Retained Earnings data on record, last reported at -$143.2 million in Q3 2025.

  • For Q3 2025, Retained Earnings rose 1.04% year-over-year to -$143.2 million; the TTM value through Sep 2025 reached -$143.2 million, up 1.04%, while the annual FY2024 figure was -$144.3 million, 0.05% changed from the prior year.
  • Retained Earnings reached -$143.2 million in Q3 2025 per NEPH's latest filing, roughly flat from -$143.5 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $68000.0 in Q1 2021 and bottomed at -$144.9 million in Q2 2024.
  • Average Retained Earnings over 5 years is -$127.1 million, with a median of -$143.2 million recorded in 2025.
  • Peak YoY movement for Retained Earnings: soared 100.05% in 2021, then tumbled 215225.76% in 2022.
  • A 5-year view of Retained Earnings shows it stood at -$135.7 million in 2021, then fell by 5.24% to -$142.8 million in 2022, then decreased by 1.1% to -$144.4 million in 2023, then grew by 0.05% to -$144.3 million in 2024, then rose by 0.78% to -$143.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$143.2 million in Q3 2025, -$143.5 million in Q2 2025, and -$143.8 million in Q1 2025.